6661 威健生技歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 42.10% | 0.75% | -0.38% | -0.69% |
| 2025Q1 | 39.93% | -6.92% | -6.30% | -6.17% |
| 2024Q4 | 42.23% | -1.30% | 0.17% | -0.41% |
| 2024Q3 | 45.06% | 6.97% | 8.32% | 8.20% |
| 2024Q2 | 41.45% | -1.33% | -1.13% | -0.90% |
| 2024Q1 | 38.82% | -7.32% | -8.14% | -8.28% |
| 2023Q4 | 39.11% | -3.38% | -4.31% | -4.33% |
| 2023Q3 | 41.62% | -1.62% | -1.72% | -1.54% |
| 2023Q2 | 46.53% | 5.60% | 8.28% | 8.00% |
| 2023Q1 | 43.67% | -9.78% | -9.94% | -9.99% |
| 2022Q4 | 39.99% | -2.71% | -2.02% | -3.56% |
| 2022Q3 | 46.59% | 8.13% | 7.66% | 6.53% |
| 2022Q2 | 46.39% | 16.77% | 13.81% | 11.85% |
| 2022Q1 | 42.17% | -5.99% | -7.06% | -7.08% |
| 2021Q4 | 45.35% | 10.61% | 14.42% | 12.78% |
| 2021Q3 | 38.35% | 0.91% | 0.17% | -0.13% |
| 2021Q2 | 42.69% | 9.20% | 8.81% | 7.65% |
| 2021Q1 | 43.84% | -9.64% | -11.42% | -11.46% |
| 2020Q4 | 42.81% | 8.49% | 10.79% | 8.82% |
| 2020Q3 | 43.44% | 10.60% | 10.77% | 9.41% |